Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

News in brief

AGC to open intermediate & API plant in Japan


AGC is to open an API and intermediate production plant in Japan to meet increased demand from the aging population.

Japan-based AGC is investing JPY3.7bn ($48m) in the 28,400 sq m manufacturing site to ramp up its active pharmaceutical ingredient (API) and intermediate business. The facility is due to open in a year and help sales at the business unit hit JPY15bn by 2014.


AGC is using its chemical technology to provide fluorinated compounds and is now adding a fourth API and intermediate plant to meet the expected growth in demand.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events


Access all events listing

Our events, Events from partners...